ELX-02 treatment improved podocyte foot process effacement in all three patients by an average of 60% based on a blinded kidney biopsy analysis by NIPOKA GmbH Biopsy results support clinical benefit ...
Many human diseases are caused by point mutations that affect RNA splicing. It has been observed that nonsense mutations that generate premature termination of translation products can drive the use ...
In Study 041, Translarna showed a significant improvement in six key study endpoints compared with placebo after 72 weeks. The Food and Drug Administration (FDA) has accepted for review the ...
Between 10 to 15% of all genetic diseases have the same underlying cause: a nonsense mutation. 1 This type of mutation results from a stop codon in the middle of a gene sequence, which terminates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results